Rapport Therapeutics, Inc. RAPP Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s financing cash flow?
- Rapport Therapeutics, Inc. (RAPP) reported financing cash flow of $531K in Q1 2026.
- How has Rapport Therapeutics, Inc.'s financing cash flow changed year-over-year?
- Rapport Therapeutics, Inc.'s financing cash flow increased by 10520.0% year-over-year, from $5K to $531K.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.